biospecimen__admin__batch_number	275.62.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	E54FB4D2-E43B-4EAE-8EDE-6D15E3B32DED
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A4NA-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A4NA-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A4NA-01A
biospecimen__bio__biospecimen_barcode_bottom	0128924836
biospecimen__bio__day_of_creation	01
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	01
biospecimen__bio__pathology_report_file_name	TCGA-DD-A4NA.48C11C04-947E-4954-9687-DF275D897F79.pdf
biospecimen__bio__plate_column	5
biospecimen__bio__plate_id	A25Z
biospecimen__bio__plate_row	H
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2012
biospecimen__bio__year_of_shipment	2013
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A4NA
biospecimen__shared__patient_id	A4NA
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	20A9BF4A-B37E-4F04-A920-E34EB4FD1F68
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.1
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.8
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	3
clinical__chol_lihc_shared__fibrosis_ishak_score	5 - Nodular Formation and Incomplete Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	10.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	9.6
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__clin_shared__age_at_initial_pathologic_diagnosis	67
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A4NA-F49640
clinical__clin_shared__bcr_followup_uuid	7A528F0A-12F2-413B-99E5-BCDEF8D66562
clinical__clin_shared__cancer_first_degree_relative	2
clinical__clin_shared__day_of_form_completion	7
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	12
clinical__clin_shared__person_neoplasm_cancer_status	TUMOR FREE
clinical__clin_shared__platelet_result_count	332
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__relative_family_cancer_history	YES
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N1
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	8791d354-886d-42e6-ae47-0eeadfad23f4
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A4NA-01A-11R-A25Z-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	095f84cc-2b6d-4423-978b-12196e4b42bd
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.94
gdc__analytes__analyte_id	370947c1-dc8a-40de-8aef-2cf14d1798dd
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	bee9d6c8-948f-4b76-97ca-b985064249ef
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:37:39.749293-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	05cba5ed-2c7e-58ae-9c00-9254139ff731
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1942
gdc__diagnoses__age_at_diagnosis	24603
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-24603.0
gdc__diagnoses__days_to_last_follow_up	1008.0
gdc__diagnoses__diagnosis_id	15269a3e-174f-561c-9783-cdb5568a5481
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiic
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	33.74945565394106
gdc__exposures__exposure_id	394979c8-ebff-56aa-9ade-2df18b9e2a5d
gdc__exposures__height	166.0
gdc__exposures__weight	93.0
gdc__file_id	cc2cc58d-f7a9-4c9a-8d4d-43236f3372be
gdc__file_name	9a24b33a-33e4-4bba-81be-cc37f5bd7e8f.mirbase21.mirnas.quantification.txt
gdc__file_size	50156
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	2c704cd6337efbcc6e9244f2873bfb5c
gdc__portions__is_ffpe	false
gdc__portions__portion_id	dbc4e639-b71a-40e9-a8ce-eb4f4bc1f183
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1198
gdc__samples__initial_weight	110.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	48C11C04-947E-4954-9687-DF275D897F79
gdc__samples__sample_id	1e7c53f1-dfb6-4a50-bd83-f8062b1306f2
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	1.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	0.0
gdc__slides__percent_tumor_cells	100.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	18b7db36-29d2-4464-9fcc-122585e0add6
gdc__submitter_id	mirna_swap_dr11_245_MirnaExpression6bc9f841-9e31-4eef-80fa-9e666f49eac1_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	9d0a5984-75a0-5ae3-a763-f3f4e768804c
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:54.028+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8791d354-886d-42e6-ae47-0eeadfad23f4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8791d354-886d-42e6-ae47-0eeadfad23f4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129527
manually_curated__local_md5	fbfd09a43496342e9bbdc286ccc6201c
manually_curated__opengdc_download_date	2018-10-16T17:10:31.000364+02:00
manually_curated__opengdc_file_md5	13efe633915704ff1c5613c2997d9c2d
manually_curated__opengdc_file_size	50155
manually_curated__opengdc_id	8791d354-886d-42e6-ae47-0eeadfad23f4-meq
manually_curated__origin_file_size	129527
manually_curated__origin_last_modified_date	Tue Oct 16 17:38:00 CEST 2018
manually_curated__origin_md5	fbfd09a43496342e9bbdc286ccc6201c
manually_curated__tissue_status	tumoral
